Company news
Nuvo Pharmaceuticals Inc news in 2012
Nuvo Pharmaceuticals Inc's news releases, calls and decks from 2012, newest first.
Nuvo Research announces 2012 third quarter results
October 31, 2012
Notice of Nuvo Research 2012 third quarter results conference call
October 29, 2012
Nuvo and Galderma Announce FDA Approval of Pliaglis®
October 22, 2012
Nuvo Research obtains additional U.S. Patent for PENNSAID® 2%
September 5, 2012
Nuvo Research announces 2012 second quarter results
August 1, 2012
Nuvo Research receives?4.4 million additional funding to develop WF10
July 26, 2012
Nuvo Research announces new listing of Synera® Patent in FDA Orange Book
July 25, 2012
Nuvo Research provides a PENNSAID® franchise update
July 23, 2012
Nuvo Research to Receive US$6.0 Million of Milestone Payments from Pliaglis® E.U. Approvals
July 19, 2012
Nuvo Research provides PENNSAID® commercial update
June 14, 2012
Nuvo Research and Paladin Labs Sign Canadian License Agreement for Synera and a Loan Agreement
May 28, 2012
Pliaglis receives positive opinion from the BfArM in the E.U.
May 7, 2012
Nuvo Research Announces 2012 First Quarter Results
May 2, 2012
FDA issues complete response letter for the Pliaglis sNDA submission
April 18, 2012
Nuvo Research Provides Pennsaid® Update
April 12, 2012
Nuvo Research to Present at the Roth Capital 24th Annual Growth Stock Conference
March 6, 2012
Nuvo Research announces 2011 fourth quarter & year-end results
February 29, 2012
Nuvo Research provides an update on its Pennsaid® franchise
February 23, 2012
Pliaglis® Regulatory Update
February 21, 2012
Nuvo Research announces launch of Synera® in the U.S.
February 2, 2012
Nuvo Research announces management change
January 9, 2012